This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​​DOZ-Medix pharmacies merger might restrict competition, Polish authority says

( November 5, 2019, 10:50 GMT | Official Statement) -- MLex Summary: Plans by Polish pharmacy operator DOZ to take over franchisee Medix might restrict competition on three local markets in the northern city of Tczew, the national competition watchdog has said. The UOKiK has raised objections to the deal, and DOZ has 14 days in which to address them.Statement follows in Polish....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login